Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

DENTSPLY SIRONA Inc. - Common Stock (NQ:XRAY)

16.70 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, May 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about DENTSPLY SIRONA Inc. - Common Stock

< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Gold Gains 1%; Halliburton Posts Weak Q3 Results
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Dentsply Sirona Stock Sinks On Dismal 2024 Guidance, Blames Macroeconomic, Competitive Pressures And Weakened Demand
Dentsply Sirona Q3 earnings beat estimates, but a $495M goodwill impairment and lowered sales outlook cause stock to drop 22%. 
Via Benzinga
Topics Earnings
Exposures Financial
Tesla To Rally Around 11%? Here Are 10 Top Analyst Forecasts For Monday
Via Benzinga
The Latest Analyst Ratings For Dentsply Sirona
Via Benzinga
Navigating 6 Analyst Ratings For Dentsply Sirona
Via Benzinga
Analyst Expectations For Dentsply Sirona's Future
Via Benzinga
A Glimpse Into The Expert Outlook On Dentsply Sirona Through 10 Analysts
Via Benzinga
Critical Insights From Dentsply Sirona Analyst Ratings: What You Need To Know
Via Benzinga
Dentsply Sirona Misses Q2 Targets - Plans Restructuring Plan Amid Weak Demand
Dentsply Sirona misses Q2 earnings, announces restructuring amid weak demand. 
Via Benzinga
XRAY Stock Earnings: Dentsply Sirona Misses EPS, Misses Revenue for Q2 2024
XRAY stock results show that Dentsply Sirona missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. 
Via InvestorPlace
XRAY Investors Have the Opportunity to Join Investigation of DENTSPLY SIRONA Inc. with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
Evaluating Dentsply Sirona: Insights From 8 Financial Analysts
Via Benzinga
Key Takeaways From Dentsply Sirona Analyst Ratings
Via Benzinga
A Glimpse Into The Expert Outlook On Dentsply Sirona Through 4 Analysts
Via Benzinga
Demystifying Dentsply Sirona: Insights From 4 Analyst Reviews
Via Benzinga
$4M Bet On This Health Care Stock? Check Out These 3 Stocks Insiders Are Buying
Via Benzinga
7 Long-Term Stocks to Buy Now: May 2024
While anything can happen in the markets from day to day, over the long-term, these seven long-term stocks to buy should prosper regardless. 
Via InvestorPlace
DENTSPLY INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Dentsply Sirona, Inc. - XRAY
From Kahn Swick & Foti, LLC
Via Business Wire
Nasdaq Gains Over 200 Points; Dentsply Sirona Shares Fall After Q1 Results
Via Benzinga
Dentsply Sirona Falls Over 4% Following Q1 Results - Read Why
Dentsply Sirona's Q1 disappoints with revenue miss at $953M, down 2.6% YoY; adjusted EPS meets expectations at 42 cents. 
Via Benzinga
Earnings Scheduled For February 29, 2024
Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million. 
Via Benzinga
Evaluating Dentsply Sirona: Insights From 8 Financial Analysts
Via Benzinga
Wednesday Is Your Last Chance To Buy Dentsply Sirona Before The Dividend Payout
Via Benzinga
XRAY Stock Earnings: Dentsply Sirona Meets EPS, Misses Revenue for Q1 2024
XRAY stock results show that Dentsply Sirona met analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
Via InvestorPlace
Sustaining Growth Momentum: Dentsply Sirona Continues to Excel and Reports Rising Profits
As the day concludes, Dentsply Sirona (NASDAQ:XRAY) is preparing to distribute a dividend payout of $0.14 per share, resulting in an annualized dividend yield of 1.65%. This payout is exclusive to... 
Via Benzinga
Insiders Buying DENTSPLY SIRONA And 2 Other Stocks
Although U.S. stocks closed lower on Monday, there were a few notable insider trades. 
Via Benzinga
This Dental Equipment Maker Has Visible EPS Growth Despite A Challenging Macro: Analyst
Needham initiated coverage on Dentsply Sirona Inc (NASDAQ: XRAY), citing its third turnaround effort since the 2016 Dentsply-Sirona merger. 
Via Benzinga
Expert Ratings for Dentsply Sirona
Via Benzinga
Why STAAR Surgical Shares Are Trading Lower By Around 16%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers OmniLit Acquisition Corp. (NASDAQ: OLIT) jumped 53.2% to $15.53. OmniLit announced that its merger with Syntec was approved by shareholders. 
Via Benzinga
< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.